leading brands of glp-1 agonists in biopharma Receptor Agonist Companies and Competitive Landscape GLP Agonist Clinical Trial Pipeline

2025;48(1 Suppl 1):S181206

They mimic the action of the natural hormone GLP-1) are a class of prescription drugs often used for type 2 diabetes medication treatment

That gap is illustrated by the case of 77yearold Anne Welch of Paris, Ont., whose physician agreed Ozempic could help her lose weight but who does not qualify for coverage because she does not have diabetes

Tschopp, J

This effect is not observed in other GLP-1RAs and is currently being studied by the drug manufacturers in the FOCUS trial (NCT03811561)

BPC-157 Strength: 10 mg Body Protecting Compound-157 A stronger mid-tier option for patients discussing more targeted support with their provider